Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
JCO Precision Oncology|May 22, 2026
Prevalence of Germline Pathogenic RET Variants in a Pan-Cancer Patient PopulationMatilde Borio, Margaret Sheehan, Nora Katabi, et al.Journal of the National Cancer Institute|July 9, 2021
Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni SyndromeOzge Ceyhan-Birsoy, Pier Selenica, M Herman Chui, et al.Genome Medicine|August 15, 2022
Diagnostic yield and clinical relevance of expanded genetic testing for cancer patientsOzge Ceyhan-Birsoy, Gowtham Jayakumaran, Yelena Kemel, et al.Journal for Immunotherapy of Cancer|October 19, 2025
Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axisAoise O'Neill, Norashikin Zakaria, Courtney Bull, et al.NPJ Precision Oncology|November 19, 2025
Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrumKelsey E Breen, Nikita Mehta, Vignesh Ravichandran, et al.Cell Reports|May 11, 2023
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironmentHannah Egan, Oliver Treacy, Kevin Lynch, et al.Gynecologic Oncology|August 14, 2025
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?Tiffany Y Sia, Sara Moufarrij, Juliet Milani, et al.Cancer|August 30, 2022
Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variantsYing L Liu, Anna Maio, Yelena Kemel, et al.Gynecologic Oncology|December 2, 2023
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survivalRyan M Kahn, Pier Selenica, Thomas Boerner, et al.Gynecologic Oncology|May 7, 2023
Germline drivers of gynecologic carcinosarcomasTiffany Y Sia, Sushmita B Gordhandas, Ozge Birsoy, et al.Pageof 5